Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. - Lindenmayer,JP.; Eerdekens,E.; Berry,SA.; Eerdekens,M. (J Clin Psychiatry, 2004)